Ocuphire Pharma is a Michigan-based clinical-stage ophthalmic biopharmaceutical company that develops and commercializes therapies for the treatment of eye disorders.
Business Model:
Revenue: $2M
Employees: 2-10
Address: 37000 Grand River Avenue
City: Farmington Hills
State: MI
Zip: 48335
Country: US
Ocuphire Pharma is a Michigan-based clinical-stage ophthalmic biopharmaceutical company that develops and commercializes therapies for the treatment of eye disorders.
Contact Phone:
+12486819815
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/6/2020
Ticker Symbol:
OCUP
IPO Price:
$16.92/share
Amount Raised:
$21M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
6/2020 | Rexahn Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|